Sarepta Therapeutics Inc (SRPT)

Debt-to-equity ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands — — — — —
Total stockholders’ equity US$ in thousands 1,527,740 859,337 384,950 928,009 761,759
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,527,740K
= 0.00

Sarepta Therapeutics Inc's debt-to-equity ratio has been consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has no debt or a negligible amount of debt in relation to its equity during this period. A debt-to-equity ratio of 0.00 is generally considered very low, suggesting that the company is primarily financed through equity rather than debt. This may signify a low financial risk and a strong financial position, as the company does not rely heavily on borrowed funds to support its operations or growth.